CADTH.ca

Begin main content

Want to browse reports and resources on high-interest topics? Visit our Evidence Bundles.

Featured Reports

New at CADTH — September 2019

News and Events CADTH is now accepting abstracts for workshops, panels, debates, breakfast sessions, oral presentations, and posters for...

Last updated: September 13, 2019

Bright Light Therapy for Depression: Clinical Effectiveness

Last updated: August 28, 2019

Ivabradine (Lancora) for Heart Failure

Heart failure is a condition characterized by reduced cardiac output occurring due to complications of cardiovascular disease. It is a le...

Last updated: June 10, 2019

View all Reports

Upcoming Events

Why Organizations, Researchers, and Patients Are Falling Prey to Predatory Journals

This interactive talk will provide an overview of what predatory journals are and describe how they are having an impact on organizati...

Event Date: October 10, 2019

CADTH Webinar — Non-Pharmacological Interventions for Chronic Non-Cancer Pain: The Science of Mindfulness

Speakers: Colleen Donder, CADTH Dr. Dzung X. Vo, BC Children’s Hospital and University of British Columbia Virginia McIntyre BA, MRT(R) (...

Event Date: October 16, 2019

View all Events

News Feed

CADTH Webinar Non-Pharmacological Interventions for Chronic Non-Cancer Pain: The Science of Mindfulness

Speakers: Colleen Donder, CADTH Dr. Dzung X. Vo, BC Children’s Hospital and University of British Columbia Due to the prevalence and bur...

Published on: August 29, 2019

Drug Reimbursement Recommendation

Today, CADTH has issued final recommendations for: Daratumumab (Darzalex) in combination with bortezomib, melphalan and prednisone for n...

Published on: August 29, 2019

Call for Patient Input and Clinical Experts: Mayzent and brolucizumab

CADTH has received the following notice(s) of pending drug submission(s). Brand name Mayzent TBC Generic name ...

Published on: August 28, 2019

View all News